CYTOF — Altamira Therapeutics Share News
0.000.00%
Last trade - 00:00Altamira surges as nasal spray shows clinical superiority in study
Brief: Altamira Therapeutics Files Provisional Patent Application For Oligophore Nanoparticles Targeting Different Kras Mutations In Cancer Treatment
Brief: Altamira Therapeutics Ltd Files For Common Stock Offering; Size Not Disclosed
Brief: Altamira Therapeutics Provides Business Update
U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics
Altamira Therapeutics slumps as nasal spray fails COVID study
Brief: Altamira Therapeutics Provides Update On Clinical Trials With Bentrio
Brief: Altamira Therapeutics Files Prospectus Relates To Resale Of Up To 400,000 Common Shares
Brief: Altamira Therapeutics Provides Business Update And First Half 2022 Financial Results
Brief: Altamira Therapeutics Announces Launch Of Bentrio In Hong Kong By Its Partner Nuance Pharma
Brief: Altamira Therapeutics Regains Listing Compliance With Nasdaq Minimum Bid Requirement
Brief: New Data Demonstrate Protective Effects Of Altamira's Bentrio Under Controlled Grass Pollen Exposure
U.S. STOCKS ON THE MOVE-Starbucks, Tesla, Wynn Resorts
Altamira Therapeutics drops on reverse stock split plan
Brief: Altamira Therapeutics Announces Reverse Stock Split
U.S. STOCKS ON THE MOVE- Boston Beer, Snap, Exxon, Oracle
U.S. STOCKS ON THE MOVE- Biohaven, Boston Beer, Exxon
Altamira Therapeutics soars on sale of inner ear development assets
Brief: Altamira Therapeutics Announces Divestiture Of Inner Ear Development Assets